RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $26,717,546 | -31.0% | 1,788,323 | +3.3% | 0.01% | -40.0% |
| Q3 2022 | $38,715,468 | +63.1% | 1,730,687 | +22.1% | 0.01% | +66.7% |
| Q2 2022 | $23,737,899 | -15.4% | 1,417,188 | +51.1% | 0.01% | 0.0% |
| Q1 2022 | $28,072,125 | +11.5% | 937,926 | +14.4% | 0.01% | +20.0% |
| Q4 2021 | $25,182,000 | +60.4% | 820,000 | +64.7% | 0.01% | +66.7% |
| Q3 2021 | $15,695,000 | +86.0% | 497,765 | +115.8% | 0.00% | +50.0% |
| Q2 2021 | $8,439,000 | +18.3% | 230,630 | +11.7% | 0.00% | 0.0% |
| Q1 2021 | $7,135,000 | -17.9% | 206,396 | -1.3% | 0.00% | 0.0% |
| Q4 2020 | $8,690,000 | – | 209,085 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
| Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
| Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
| BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
| Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
| EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
| Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
| HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |